Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7321 p558
16 October 2004

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Adherence
· Medicines waste
· Community pharmacy
· Brand names
· Tuberculosis
· CPD
· Counterfeit medicines
· Geography


Letters to the Editor

Community pharmacy

Staff are overwhelmed by new “opportunities”

From Miss C. M. Watson, MRPharmS

I would like to comment on letters from Ken Sagar and Mitul Patel (PJ, 2 October, p466 and p465) because they eloquently express concerns that I also have.

I do not think what Mr Sagar experienced is acceptable dispensing practice. Unfortunately his experience is being repeated by thousands of patients the length and breadth of Britain. Patients are being confronted with a “dolly mixture” assortment of medicines when they receive their repeat prescriptions. There is no continuity of packaging and the size, colour and shape of tablets and capsules can vary depending on source.

I note that patient representative groups are beginning to take issue with this problem. We are being encouraged to take on new roles but in my opinion we are not even performing our core role properly. All the counselling in the world will not convince a worried elderly patient with perhaps four or more repeat medicines that a pink and white capsule one month is the same as a purple and grey one the next. We have no idea if the lack of continuity in appearance of medicines is affecting compliance.

The argument that our skilled buying is keeping the drugs bill down is a red herring. (Generic manufacturers are being investigated for price fixing.) The issue of parallel imports being cheaper than UK-sourced drugs has not been tackled either. Counterfeit drugs are already in the supply chain. How can this be described as a professional service?

Mr Patel has described a typical scenario in many community pharmacies. Staff are overwhelmed by new “opportunities”, increased volume of dispensing, model schemes, patient group directives, standard operating procedures, grandparent clauses, staff training, audit, increased demand for information on medicines, alternative therapies, health promotion etc. The list is endless. I find I now dread hearing the words “a customer would like a word with you” because I know if I spend 10 minutes with them there will be a build up of tasks waiting for my attention. This saddens me because this used to be my favourite part of my practice. I think I must be burnt out.

Catherine Watson
Tain, Ross-shire

Send your letter to The Editor

Previous Topic (Medicines waste)
Next Topic (Brand names)

Back to Top


©The Pharmaceutical Journal